FDA Inspection 768767 — davAgen Pharmaceuticals LLC

davAgen Pharmaceuticals LLC — FEI 3008962805

The FDA completed an inspection of davAgen Pharmaceuticals LLC on Feb 27, 2012 in Somerset, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 27, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Somerset, NJ (United States)

Citations

IDCFRDescription
344521 CFR 211.65(a)Equipment construction - reactive surfaces
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
440321 CFR 211.194(b)Test method modification records do not include

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.